EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Fusing a Novel Anti-CTLA-4 Nanobody to the IgG1 Fc Region Strengthens Its Ability to Induce CD8+ T Cell-Mediated Immune Responses Against Solid Tumors

Ting-Ting Li, Jin-Hua Yang, Meng-Jie Jiang, Hao-Peng Cui, Xiao-Mei Yang, Xiao-Ling Lu, Ai-Qun Liu iD

International Journal of Nanomedicine · 2024

DOI: 10.2147/ijn.s480939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2024. Verfasst von Ting-Ting Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Respiratory Medicine & Endoscopy Center, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, Peo…. Hauptthemen laut MEDLINE: CD8-Positive T-Lymphocytes, CTLA-4 Antigen, Single-Domain Antibodies, Immunoglobulin G. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CD8-Positive T-LymphocytesCTLA-4 AntigenSingle-Domain AntibodiesImmunoglobulin GImmunoglobulin Fc FragmentsMice, NudeAnimalsHumansMiceCell Line, TumorRecombinant Fusion ProteinsXenograft Model Antitumor AssaysNeoplasmsCell ProliferationFemaleDendritic CellsLymphocyte Activation

Stichwörter der Autor:innen

CTLA-4adoptive immunotherapycell fusionnanobodytherapeutic antibody derivative

Substanzen

CTLA-4 AntigenSingle-Domain AntibodiesImmunoglobulin GImmunoglobulin Fc FragmentsRecombinant Fusion Proteins

Autor:innen und Institutionen

  • Department of Gastroenterology and Respiratory Medicine & Endoscopy Center, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, 530021, People's Republic of China.
  • Guangxi Key Laboratory of Nanobody Research, Guangxi Medical University, Nanning, Guangxi, 530021, People's Republic of China.

ORCID-Profile: Ai-Qun Liu

Zitieren

APA

Li, T. T., Yang, J. H., Jiang, M. J., Cui, H. P., Yang, X. M., Lu, X. L., & Liu, A. Q. (2024). Fusing a Novel Anti-CTLA-4 Nanobody to the IgG1 Fc Region Strengthens Its Ability to Induce CD8+ T Cell-Mediated Immune Responses Against Solid Tumors. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s480939

Vancouver

Li TT, Yang JH, Jiang MJ, Cui HP, Yang XM, Lu XL, et al. Fusing a Novel Anti-CTLA-4 Nanobody to the IgG1 Fc Region Strengthens Its Ability to Induce CD8+ T Cell-Mediated Immune Responses Against Solid Tumors. International Journal of Nanomedicine. 2024. doi:10.2147/ijn.s480939

BibTeX
@article{Li2024,
  author = {Li, Ting-Ting and Yang, Jin-Hua and Jiang, Meng-Jie and Cui, Hao-Peng and Yang, Xiao-Mei and Lu, Xiao-Ling and Liu, Ai-Qun},
  title = {Fusing a Novel Anti-CTLA-4 Nanobody to the IgG1 Fc Region Strengthens Its Ability to Induce CD8+ T Cell-Mediated Immune Responses Against Solid Tumors},
  journal = {International Journal of Nanomedicine},
  year = {2024},
  doi = {10.2147/ijn.s480939}
}
Kostenlos starten →